BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Hemostemix’ $1,000,000 Private Placement and Update

  June 18, 2026

   · 

  10 min read
• Press Releases

  Envoy Medical to Present at Investor Conferences on June 25th

  June 18, 2026

   · 

  2 min read
• Press Releases

  MustGrow Increases Non-Brokered LIFE Offering to Approximately $3.7 Million

  June 18, 2026

   · 

  6 min read
• Press Releases

  Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods

  June 18, 2026

   · 

  6 min read
• Press Releases

  BioHarvest Sciences to Present at the 2026 BIO International Convention

  June 18, 2026

   · 

  5 min read
• 

  FDA

  At FDA, ‘caretaker mode’ is better than power trip mode

  UniQure’s planned third-quarter submission for its Huntington’s disease gene therapy may be a harbinger of a more flexible FDA under acting commissioner Kyle Diamantas—but how long will it last? And how can companies be sure these positive decisions won’t just be reversed?

  June 18, 2026

   · 

  6 min read

   · 

  Heather McKenzie